Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: Cage Rattler who wrote (532)	10/18/1998 5:10:00 PM
From: Tagore	Read Replies (2) \| Respond to of 1255

It's the size of the potential markets that has attracted me to Cortex- don't forget the schizophrenia application which is huge and the recent results on depression which is also humongous. The ampikines apparently can be formulated for different mental diseases. I am, however, troubled why the CFO would leave just as they are about to do the first partnership. Murphy says it is a matter of a better position at another biotech, but still it doesn't make sense to leave just when dawn and options are about to break.